Skip to main content
. 2014 Jun 10;4:5232. doi: 10.1038/srep05232

Figure 4.

Figure 4

(A) Tumor total antibody concentration profile after 1 h circulation for BT474 illustrating how the antibody penetrates deeper into the tumor when iRGD is present. (B) Plot of simulation %ID/g vs Antibody (Ab) dose after 1 h circulation with and without iRGD for the 4T1 tumor model and (C) for BT474 tumor model.